However, autoantibodies against TOPO48, HNRNPF, and FTH1 in BC have been only described in one study, and thus, more research is needed to establish this biomarker panel for BC clinical diagnosis (Table 1). The gene discussed is HNRNPF; the disease is breast cancer.